Epithalon 10 - Livewell Pharmaceuticals

Epitalon was discovered by Russian scientists at Saint Petersburg University in the 1990s. Derived from the pineal extract Epithalamin, it emerged as a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly. It showed promise in animal studies by extending lifespan, enhancing insulin sensitivity, reducing carcinogenesis, and increasing melatonin levels. First introduced at the 1999 Pan-American Congress on Gerontology, it remains an experimental agent, available only as a research chemical without pharmaceutical approval.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Epithalon 10 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.